Related Experiment Videos
Rheumatic fever prophylaxis: Gisborne experience
Abstract:
There were 300 admissions to the Cook Hospital with rheumatic fever in 1958-83. During 1958-73 oral penicillin was used for secondary prophylaxis and 77 (35%) of 223 admissions were recurrences. From 1974-83 when parenteral benzathine penicillin was increasingly used there were 77 admissions of which 14 (18%) were readmissions. An effective programme of secondary prophylaxis using benzathine penicillin and co-ordination of hospital and community health services is outlined. One hundred and eight patients with a first attack of rheumatic fever were seen in 1968-82. The chance of a recurrence in patients in whom oral prophylaxis was instituted was 15% two years after the initial attack and 35% after six years. Institution of parenteral prophylaxis significantly reduced the risk of recurrence (p = 0.0009) which was 2% six years after the first attack.
Insights
Parenteral benzathine penicillin significantly reduced rheumatic fever recurrence rates compared to oral penicillin. This injectable form of prophylaxis is highly effective for secondary prevention in rheumatic fever patients.
Area of Science:
- Cardiology
- Infectious Diseases
- Public Health
Background:
- Rheumatic fever poses a significant risk of recurrent episodes, leading to severe cardiac complications.
- Secondary prophylaxis is crucial in preventing recurrent attacks of rheumatic fever.
Purpose of the Study:
- To evaluate the effectiveness of different penicillin prophylaxis strategies for secondary prevention of rheumatic fever.
- To compare recurrence rates between oral and parenteral benzathine penicillin administration.
Main Methods:
- Retrospective analysis of 300 rheumatic fever admissions at Cook Hospital (1958-1983).
- Comparison of recurrence rates in patients receiving oral penicillin (1958-1973) versus parenteral benzathine penicillin (1974-1983).
- Statistical analysis to determine the significance of recurrence risk reduction with parenteral prophylaxis.
Main Results:
- Recurrence rates decreased from 35% with oral penicillin to 18% with parenteral benzathine penicillin.
- Parenteral prophylaxis significantly reduced the risk of recurrence (p = 0.0009).
- Six years after the first attack, recurrence risk was 35% with oral prophylaxis versus 2% with parenteral prophylaxis.
Conclusions:
- Parenteral benzathine penicillin is a highly effective method for secondary prophylaxis of rheumatic fever.
- Coordinated hospital and community health services are essential for an effective prophylaxis program.
- Transitioning to parenteral penicillin significantly lowers long-term recurrence risk.